Protect Pharmaceutic has returned -96.0% from $1.51 since 2021, trailing SPY's +70.5% over the same period. The stock hit an all-time high of $3.10 in Jan 2024 and is currently 98.1% below that level. Of 5 tracked news events, 60% produced a positive market-adjusted return.
Expand to read Wikipedia-sourced background on the company. Click any linked term to explore it inline — no page reload.
Common questions answered from real data: performance vs SPY, market cap, profitability, CEO, dividends, and more.
Every dot on the chart is a news event. The return shown is market-adjusted (vs SPY). Green = stock outperformed. Red = underperformed. Dot size = magnitude of reaction.
Want the full written briefing?
The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.
| Date | Return | Category | Source | Headline |
|---|---|---|---|---|
| 2025-04-25 | -28.0% | news | Stock Titan | PRTT Stock Price, News & Analysis - Stock Titan |
| 2024-09-03 | -23.4% | M&A | Seeking Alpha | Protect Pharmaceutical announces that KARINCA logistics merger will not proceed |
| 2023-03-08 | +15.8% | news | Seeking Alpha | Protect Pharmaceutical announces new president Ali Vildiz |
| 2023-11-24 | +13.8% | M&A | Seeking Alpha | Protect Pharmaceutical acquires Bosfor Export |
| 2024-08-15 | +9.7% | executive | Seeking Alpha | Protect Pharmaceutical names Ozgur Ozcan as CEO |